Evidence map›Paper›PMID 40067889›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

NBS1 facilitates preribosomal RNA biogenesis.

Man Luo, Xiaochun Yu

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Peroxiredoxin 1 safeguards the nucleolar genome from oxidative damage.bioRxiv : the preprint server for biology · 2025
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Man LuoSchool of Life Sciences, Fudan University, Shanghai 200438, China.ORCID 0009-0000-0947-5350
Xiaochun YuWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang 310030, China.ORCID 0000-0001-9840-2670

Funding

Hangzhou City Leading Innovation and Entrepreneurship Team TD2020004"Pioneer" and "Leading Goose" R&D Program of Zhejiang 2024SSYS0033the National Natural Science Foundation of China 32090034 and 81874160Zhejiang Provincial Natural Science Foundation of China 2022XHSJJ001
6 · The paper itself

Abstract

Mutations in the

Indexed as

Cell Cycle ProteinsCell NucleolusNuclear ProteinsRNA, RibosomalTranscription, GeneticAnimalsDNA-Binding ProteinsFaceHumansIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutMutationPhosphoproteinsRNA Polymerase IRNA PrecursorsCell Cycle ProteinsDNA-Binding ProteinsIntracellular Signaling Peptides and ProteinsNBN protein, humanNijmegen breakage syndrome 1 protein, mouseNuclear ProteinsPhosphoproteinsRNA Polymerase IRNA PrecursorsRNA, RibosomalTcof1 protein, mouseNBS1nucleoluspreribosomal RNA

Identifiers

PMID40067889
PMCPMC11929472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.